Aytu Biopharma (AYTU) Amortization - Intangibles (2016 - 2025)
Historic Amortization - Intangibles for Aytu Biopharma (AYTU) over the last 11 years, with Q4 2025 value amounting to $526000.0.
- Aytu Biopharma's Amortization - Intangibles fell 4288.82% to $526000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 million, marking a year-over-year decrease of 2367.64%. This contributed to the annual value of $3.7 million for FY2025, which is 0.0% changed from last year.
- Per Aytu Biopharma's latest filing, its Amortization - Intangibles stood at $526000.0 for Q4 2025, which was down 4288.82% from $444000.0 recorded in Q3 2025.
- Aytu Biopharma's Amortization - Intangibles' 5-year high stood at $1.6 million during Q1 2021, with a 5-year trough of $444000.0 in Q3 2025.
- Moreover, its 5-year median value for Amortization - Intangibles was $1.1 million (2023), whereas its average is $1.1 million.
- In the last 5 years, Aytu Biopharma's Amortization - Intangibles surged by 1561.02% in 2021 and then tumbled by 5179.15% in 2025.
- Aytu Biopharma's Amortization - Intangibles (Quarter) stood at $1.5 million in 2021, then dropped by 20.4% to $1.2 million in 2022, then decreased by 23.37% to $918000.0 in 2023, then grew by 0.33% to $921000.0 in 2024, then plummeted by 42.89% to $526000.0 in 2025.
- Its Amortization - Intangibles stands at $526000.0 for Q4 2025, versus $444000.0 for Q3 2025 and $921000.0 for Q2 2025.